Adalimumab-adaz Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Adalimumab-adaz Injection (injection) from Sandoz Inc. with status To Be Discontinued. The shortage was first posted on Jan 13, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Sandoz Inc.
- Package NDC
- 61314-531-64
- Dosage Form
- Injection
- Presentation
- Hyrimoz, Injection, Kit (NDC 61314-531-64)
- Initial Posting
- Jan 13, 2026